Blood test could offer simpler way to guide lung cancer treatment
NCT ID NCT07432308
Summary
This study tested a new blood test method designed to detect genetic changes in advanced non-small cell lung cancer. Researchers analyzed blood samples from 22 patients to see if the test could reliably identify these changes compared to standard tissue-based tests. The goal was to evaluate if this 'liquid biopsy' could be a practical tool to help guide personalized treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.